Advertisement
Review| Volume 122, ISSUE 11, P977-991, November 2009

An Umbrella Review: Corticosteroid Therapy for Adults with Acute Asthma

      Abstract

      The objective of this “umbrella” review is to synthesize the evidence and provide clinicians a single report that summarizes the state of knowledge regarding the use of corticosteroids in adults with acute asthma. Systematic reviews in the Cochrane Library and additional clinical trials published in English from 1966 to 2007 in MEDLINE, EMBASE, CINAHL, and Cochrane CENTRAL, and references from bibliographies of pertinent articles were reviewed. Results indicate that the evidence base is frequently limited to small, single-center studies. Findings suggest that therapy with systemic corticosteroids accelerates the resolution of acute asthma and reduces the risk of relapse. There is no evidence that corticosteroid doses greater than standard doses (prednisone 50-100 mg equivalent) are beneficial. Oral and intravenous corticosteroids, as well as intramuscular and oral corticosteroid regimens, seem to be similarly effective. A nontapered 5- to 10-day course of corticosteroid therapy seems to be sufficient for most discharged patients. Combinations of oral and inhaled corticosteroids on emergency department/hospital discharge might minimize the risk of relapse.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to The American Journal of Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • National Heart, Blood, and Lung Institute
        National Asthma Education and Prevention Program.
        National Institutes of Health, Bethesda, MD2007 (Publication No. 08-4051)
        • National Institutes of Health/National Heart, Lung, and Blood Institute
        Data fact sheet, asthma statistics. January 1999.
        (Accessed September 21, 2008)
        • Atmar R.L.
        • Guy E.
        • Guntupalli K.K.
        • et al.
        Respiratory tract viral infections in inner-city asthmatic adults.
        Arch Intern Med. 1998; 158: 2453-2459
        • Rosenstreich D.L.
        • Eggleston P.
        • Kattan M.
        • et al.
        The role of cockroach allergy and exposure to cockroach allergen in causing morbidity among inner-city children with asthma.
        N Engl J Med. 1997; 336: 1356-1363
        • Friedman M.S.
        • Powell K.E.
        • Hutwagner L.
        • et al.
        Impact of changes in transportation and commuting behaviors during the 1996 Summer Olympic Games in Atlanta on air quality and childhood asthma.
        JAMA. 2001; 285: 897-905
        • Romieu I.
        • Meneses F.
        • Sienra-Monge J.J.
        • et al.
        Effects of urban air pollutants on emergency visits for childhood asthma in Mexico City.
        Am J Epidemiol. 1995; 141: 546-553
        • Galan I.
        • Tobias A.
        • Banegas J.R.
        • et al.
        Short-term effects of air pollution on daily asthma emergency room admissions.
        Eur Respir J. 2003; 22: 802-808
        • Lemiere C.
        • Bai T.
        • Balter M.
        • et al.
        Adult asthma consensus guidelines update 2003.
        Can Respir J. 2004; 11: 9A-18A
        • Stellato C.
        Glucocorticoid actions on airway epithelial responses in immunity: functional outcomes and molecular targets.
        J Allergy Clin Immunol. 2007; 120: 1247-1263
        • Rodrigo G.
        • Rodrigo C.
        Corticosteroids in the emergency department therapy of acute asthma.
        Chest. 1999; 116: 285-295
        • Manser R.
        • Reid D.
        • Abramson M.
        Corticosteroids for acute severe asthma in hospitalised patients.
        Cochrane Database Syst Rev. 2001; 1 (CD001740)
        • Rowe B.H.
        • Spooner C.H.
        • Ducharme F.M.
        • Bretzlaff J.A.
        • Bota G.W.
        Early emergency department treatment of acute asthma with systemic corticosteroids.
        Cochrane Database Syst Rev. 2001; 1 (CD002178)
        • Rowe B.H.
        • Spooner C.H.
        • Ducharme F.M.
        • Bretzlaff J.A.
        • Bota G.W.
        Corticosteroids for preventing relapse following acute exacerbations of asthma.
        Cochrane Database Syst Rev. 2007 July 18; 13 (CD000195)
        • Edmonds M.L.
        • Camargo Jr, C.A.
        • Saunders L.D.
        • et al.
        Inhaled steroids in acute asthma following emergency department discharge.
        Cochrane Database Syst Rev. 2000; 3 (CD002316)
        • McFadden Jr, E.R.
        • Kiser R.
        • deGroot W.J.
        • et al.
        A controlled study of the effects of single doses of hydrocortisone on the resolution of acute attacks of asthma.
        Am J Med. 1976; 60: 52-59
        • Medical Research Council
        Controlled trials of effect of cortisone acetate in status asthmaticus.
        Lancet. 1956; 2: 803-806
        • Fanta C.H.
        • Rossing T.H.
        • McFadden E.R.
        Glucocorticoids in acute asthma.
        Am J Med. 1983; 74: 845-851
        • Ratto D.
        • Alfaro C.
        • Sipsey J.
        • et al.
        Are intravenous corticosteroids required in status asthmaticus?.
        JAMA. 1988; 260: 527-529
        • Jones A.M.
        • Munavvar M.
        • Vail A.
        • et al.
        Prospective, placebo-controlled trial of 5 vs 10 days of oral prednisone in acute adult asthma.
        Respir Med. 2002; 96: 950-954
        • Hasegawa T.
        • Ishihara K.
        • Takakura S.
        • et al.
        Duration of systemic corticosteroids in the treatment of asthma exacerbation; a randomized study.
        Intern Med. 2000; : 794-797
        • Cydulka R.K.
        • Emerman C.L.
        A pilot study of steroid therapy after emergency department treatment of acute asthma: is a taper needed?.
        J Emerg Med. 1998; 16: 15-19
        • Karan R.S.
        • Pandhi P.
        • Behera D.
        • et al.
        A comparison of non-tapering vs tapering prednisolone in acute exacerbation of asthma involving use of the low-dose ACTH test.
        Int J Clin Pharmacol Ther. 2002; 40: 256-262
        • Hatton M.Q.F.
        • Vathenen A.S.
        • Allen M.J.
        • et al.
        A comparison of abruptly stopping with tailing off oral corticosteroids in acute asthma.
        Respir Med. 1995; 89: 101-104
        • O'Driscoll B.R.
        • Kalra S.
        • Wilson M.
        • et al.
        Double-blind trial of steroid tapering in acute asthma.
        Lancet. 1993; 341: 324-327
        • Lederle F.A.
        • Pluhar R.E.
        • Joseph A.M.
        • Niewoehner D.E.
        Tapering corticosteroid therapy following exacerbation of asthma.
        Arch Intern Med. 1987; 147: 2201-2203
        • Lahn M.
        • Bijur P.
        • Gallagher E.J.
        Randomized clinical trial of intramuscular vs oral methylprednisolone in the treatment of asthma exacerbations following discharge from an emergency department.
        Chest. 2004; 126: 362-368
        • Chan J.S.
        • Cowie R.L.
        • Lazarenko G.C.
        • et al.
        Comparison of intramuscular betamethasone and oral prednisone in the prevention of relapse of acute asthma.
        Can Respir J. 2001; 8: 147-152
        • Schuckman H.
        • DeJulius D.P.
        • Blanda M.
        • et al.
        Comparison of intramuscular triamcinolone and oral prednisone in the outpatient treatment of acute asthma: a randomized controlled trial.
        Ann Emerg Med. 1998; 31: 333-338
        • Structure of a Cochrane Review
        (Accessed February 19, 2005)
        • American Academy of Pediatrics: Policy Statement
        Classifying Recommendations for Clinical Practice Guidelines.
        Pediatrics. 2004; 114: 874-877
        • Lin R.Y.
        • Pesola G.R.
        • Westfal R.E.
        • et al.
        Early parenteral corticosteroid administration in acute asthma.
        Am J Emerg Med. 1997; 7: 621-625
        • Lin R.Y.
        • Pesola G.R.
        • Bekalchuk L.
        • et al.
        Rapid improvement in peak flow in asthmatic patients treated with parenteral methylprednisolone in the emergency department: a randomized controlled study.
        Ann Emerg Med. 1999; 33: 487-494
        • Littenberg B.
        • Gluck E.
        A controlled trial of methylprednisolone in the emergency treatment of acute asthma.
        N Engl J Med. 1986; 314: 150-152
        • Rodrigo C.
        • Rodrigo G.
        Early administration of hydrocortisone in the emergency room treatment of acute asthma: a controlled clinical trial.
        Respir Med. 1994; 88: 755-761
        • Schneider S.M.
        • Piper A.
        • Britton H.L.
        • et al.
        High-dose methylprednisolone as initial therapy in patients with acute bronchospasm.
        J Asthma. 1988; 25: 189-193
        • Stein L.M.
        • Cole R.P.
        Early administration of corticosteroids in emergency room treatment of acute asthma.
        Ann Intern Med. 1990; 112: 822-827
        • Bowler S.D.
        • Mitchell C.A.
        • Armstrong J.G.
        Corticosteroids in acute severe asthma: effectiveness of low doses.
        Thorax. 1992; 47: 584-587
        • Engel T.
        • Dirksen A.
        • Frolund L.
        • et al.
        Methylprednisolone pulse therapy in acute severe asthma: a randomized, double-blind study.
        Allergy. 1990; 45: 224-230
        • Haskell R.J.
        • Wong B.M.
        • Hansen J.E.
        A double-blind, randomized clinical trial of methylprednisolone in status asthmaticus.
        Arch Intern Med. 1983; 143: 1324-1327
        • Marquette C.H.
        • Stach B.
        • Cardot E.
        • et al.
        High dose and low dose systematic corticosteroids are equally efficient in acute severe asthma.
        Eur Respir J. 1995; 8: 22-27
        • Harrison B.D.
        • Stokes T.C.
        • Hart G.J.
        • et al.
        Need for intravenous hydrocortisone in addition to oral prednisolone in patients admitted to hospital with severe asthma without ventilatory failure.
        Lancet. 1986; 1: 181-184
        • Guest J.F.
        • Davie A.M.
        • Ruiz F.J.
        • et al.
        Switching asthma patients to a once-daily inhaled steroid improves compliance and reduces healthcare costs.
        Prim Care Respir J. 2005; 14: 88-98
        • Krishnan J.A.
        • Riekert K.A.
        • McCoy J.V.
        • et al.
        Corticosteroid use after hospital discharge among high-risk adults with asthma.
        Am J Respir Crit Care Med. 2004; 170: 1281-1285
        • Cooper W.O.
        • Hickson G.B.
        Corticosteroid prescription filling for children covered by Medicaid following an emergency department visit or a hospitalization for asthma.
        Arch Pediatr Adolesc Med. 2001; 155: 1111-1115
        • Williams L.K.
        • Pladevall M.
        • Xi H.
        • et al.
        Relationship between adherence to inhaled corticosteroids and poor outcomes among adults with asthma.
        J Allergy Clin Immunol. 2004; 114: 1288-1293
        • Hoffman I.B.
        • Feil S.B.
        Oral versus repository corticosteroid therapy in acute asthma.
        Chest. 1988; 93: 11-13
        • Lee C.-H.
        • Lee C.-J.
        • Lan R.-S.
        • et al.
        Repository dexamethasone in the treatment of acute bronchial asthma.
        Changgeng Yi Xue Za Zhi. 1993; 16: 25-29
        • Rowe B.H.
        • Bota G.W.
        • Fabris L.
        • et al.
        Inhaled budesonide in addition to oral corticosteroids to prevent relapse following discharge from the emergency department: a randomized controlled trial.
        JAMA. 1999; 281: 2119-2126
        • Brenner B.E.
        • Chavda K.K.
        • Camargo C.A.
        Randomized trial of inhaled flunisolide versus placebo among asthmatic patients discharged from the emergency department.
        Ann Emerg Med. 2000; 36: 417-426
        • Camargo Jr, C.A.
        • MARC Investigators
        Randomized trial of medium-dose fluticasone vs placebo after an emergency department visit for acute asthma.
        J Allergy Clin Immunol. 2000; 105 ([abstract]): S262
        • Sin D.D.
        • Man S.F.
        Low-dose inhaled corticosteroid therapy and risk of emergency department visits for asthma.
        Arch Intern Med. 2002; 164: 1591-1595
        • Blais L.
        • Ernst P.
        • Boivin J.-F.
        • Suissa S.
        Inhaled corticosteroids and the prevention of readmission to hospital of asthma.
        Am J Respir Crit Care Med. 1998; 158: 126-132
        • Camargo Jr, C.A.
        • Smithline H.A.
        • Malice M.P.
        • et al.
        A randomized controlled trial of intravenous montelukast in acute asthma.
        Am J Respir Crit Care Med. 2003; 167: 528-533
        • Silverman R.A.
        • Nowak R.M.
        • Korenblat P.E.
        • et al.
        Zafirlukast treatment for acute asthma: evaluation in a randomized, double-blind, multicenter trial.
        Chest. 2004; 126: 1480-1489
        • Rowe B.H.
        • Wong E.
        • Blitz S.
        • et al.
        Adding long-acting beta-agonists to inhaled corticosteroids after discharge from the emergency department for acute asthma: a randomized controlled trial.
        Acad Emerg Med. 2007; 14: 833-840
        • Green R.H.
        • Brightling C.E.
        • McKenna S.
        • et al.
        Asthma exacerbations and sputum eosinophil counts: a randomized controlled trial.
        Lancet. 2002; 360: 1715-1721
        • Lim K.G.
        • Mottram C.
        The use of fraction of exhaled nitric oxide in pulmonary practice.
        Chest. 2008; 133: 1232-1242
        • Baptist A.P.
        • Sengupta R.
        • Pranathiageswaran S.
        • et al.
        Evaluation of exhaled nitric oxide measurements in the emergency department for patients with acute asthma.
        Ann Allergy Asthma Immunol. 2008; 100: 415-419
        • Baptist A.P.
        • Shah B.
        • Wang Y.
        • et al.
        Exhaled nitric oxide levels during treatment in patients hospitalized with asthma.
        Allergy Asthma Proc. 2008; 29: 171-176
        • Gibson P.G.
        • Simpson J.L.
        • Saltos N.
        Heterogeneity of airway inflammation in persistent asthma.
        Chest. 2001; 119: 1329-1336
        • Ordonez C.L.
        • Shaughnessy T.E.
        • Matthay M.A.
        • et al.
        Increased neutrophil numbers and IL-8 levels in airway secretions in acute severe asthma.
        Am J Respir Crit Care Med. 2000; 161: 1185-1190
        • Norzila M.Z.
        • Fakes K.
        • Henry R.L.
        • et al.
        Interleukin-8 secretion and neutrophil recruitment accompanies induced sputum eosinophil activation in children with acute asthma.
        Am J Respir Crit Care Med. 2000; 161: 769-774
        • Haldar P.
        • Pavord I.D.
        Noneosinophilic asthma: a distinct clinical and pathologic phenotype.
        J Allergy Clin Immunol. 2007; 119: 1043-1052
        • Johnston S.L.
        • Blasi F.
        • Black P.N.
        • et al.
        • TELICAST Investigators
        The effect of telithromycin in acute exacerbations of asthma.
        N Engl J Med. 2006; 354: 1589-1600
        • Simpson J.L.
        • Powell H.
        • Boyle M.J.
        • et al.
        Clarithromycin targets neutrophilic airway inflammation in refractory asthma.
        Am J Respir Crit Care Med. 2008; 177: 148-155
        • De Palma A.M.
        • Vliegen I.
        • De Clercq E.
        • Neyts J.
        Selective inhibitors of picornavirus replication.
        Med Res Rev. 2008; 28: 823-884
        • Castro M.
        • Zimmerman N.A.
        • Crocker S.
        • et al.
        Asthma intervention program prevents readmission in high healthcare users.
        Am J Respir Crit Care Med. 2003; 168: 1095-1099